Organigram reported a strong quarter with record-breaking revenue and significant market share in Canada, supported by international expansion and operational improvements. However, challenges with ERP integration and delays in EU GMP certification presented some setbacks. Despite these challenges, the company's positive cash flow and strategic initiatives suggest a strong long-term trajectory.

Company Guidance

During the Organigram Global Third Quarter Fiscal 2025 Earnings Conference Call, the company reported a record-breaking quarter in both gross and net revenue, driven by growth in the Canadian recreational cannabis market and international expansion. In Q3, the Canadian market grew by 6.6% year-over-year, reaching $1.4 billion in retail sales, with Organigram maintaining its position as the #1 licensed producer nationally with an 11.6% market share. The company continued to lead in the vape and pre-roll segments, holding 20.4% and 8.3% of the national market, respectively. Notably, the SHRED brand achieved a 69% repurchase rate across its participating categories. Organigram also saw significant gains in edibles, achieving an 18.2% market share by the end of July. Operational highlights included a 15% increase in harvest at the Moncton facility and ongoing capacity enhancements expected to add 14,000 kilograms of annual capacity. International revenue reached $7.4 million, indicating a 208% year-over-year and 21% sequential increase, primarily driven by exports to Germany, Australia, and the U.K. The company continues to explore strategic international investments with $59 million available in their Jupiter pool.

Record-Breaking Revenue and Growth

Organigram reported record-breaking gross and net revenue for Q3 Fiscal 2025, with gross sales increasing 73% year-over-year and 7.2% sequentially to reach $110.2 million. Net revenue was $70.8 million, a 72% year-over-year increase and a 7.9% sequential increase.

Strong Market Position in Canada

Organigram maintained its position as the #1 licensed producer nationally in Canada with an 11.6% market share. The company held 20.4% of the national vape segment and 8.3% of the pre-roll segment.

International Expansion

International revenue increased by 208% year-over-year and 21% sequentially to $7.4 million, driven by exports to Germany, Australia, and the U.K.

Operational Improvements and Capacity Expansion

Harvested over 24,000 kilograms at the Moncton facility, a 15% increase over Q2. LED light upgrades and nutrient optimizations increased annual capacity by over 14,000 kilograms.

Positive Cash Flow

Generated free cash flow of $5 million in Q3 and expect to generate positive free cash flow in Q4 and throughout fiscal 2026.

OrganiGram Holdings (OGI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OGI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Dec 02, 2025	2025 (Q4)	>-0.01 / -	-0.033	―	―	―
Aug 13, 2025	2025 (Q3)	>-0.01 / -0.04	0.02	-278.57% (-0.06)
May 12, 2025	2025 (Q2)	-0.03 / 0.23	-0.164	240.97% (+0.40)
Feb 11, 2025	2025 (Q1)	-0.02 / -0.14	-0.127	-14.29% (-0.02)
Dec 18, 2024	2024 (Q4)	-0.03 / -0.03	-0.294	88.92% (+0.26)
Aug 13, 2024	2024 (Q3)	-0.05 / 0.02	-1.921	101.06% (+1.94)
May 14, 2024	2024 (Q2)	-0.06 / -0.16	-0.061	-170.24% (-0.10)
Feb 13, 2024	2024 (Q1)	-0.09 / -0.13	0.063	-301.15% (-0.19)
Dec 19, 2023	2023 (Q4)	- / -0.29	0.063	-566.67% (-0.36)
Jul 14, 2023	2023 (Q3)	-0.05 / -1.92	-0.023	-8187.50% (-1.90)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OGI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 13, 2025	$1.59	$1.60	+0.63%
May 12, 2025	$1.18	$1.28	+8.47%
Feb 11, 2025	$1.73	$1.44	-16.76%
Dec 18, 2024	$1.61	$1.47	-8.70%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does OrganiGram Holdings (OGI) report earnings?

OrganiGram Holdings (OGI) is schdueled to report earning on Dec 02, 2025, TBA (Confirmed).

What is OrganiGram Holdings (OGI) earnings time?

OrganiGram Holdings (OGI) earnings time is at Dec 02, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OGI EPS forecast?

OGI EPS forecast for the fiscal quarter 2025 (Q4) is >-0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing